Remove Collective Remove Conditions Remove Data Remove THC
article thumbnail

Wearables data: CBD+CBN+THC can support deeper sleep

The Cannigma

1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.

Sleep 95
article thumbnail

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. Like THC , CBN is a natural anti-inflammatory. CBN acts like a weaker version of THC at CB1 receptors, causing very few of THC’s impairing effects, and also less side effects.

Sleep 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis consumers, real-world data, and why it matters

The Cannigma

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88
article thumbnail

Papa’s Herb® Enters the Oregon Market Through Halo Collective

Cannabis Law Report

TORONTO , July 19, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a brand licensing arrangement (the “Licensing Agreement”) with Brezwald Corp.

article thumbnail

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100
article thumbnail

A big player staying committed to craft: Introducing Trulieve’s Cultivar Collection

SpeedWeed

The new Cultivar Collection from Trulieve demonstrates how a multi-state player can stay craft at its core. Crafting the Cultivar Collection. The proof is in the pudding with Trulieve’s new Cultivar Collection. Grape Cake from the Cultivar Collection. The Cultivar Collection was no overnight feat.

article thumbnail

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

Cannabis Law Report

The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. To the best of our knowledge, this is the first human clinical trial combining low doses of THC with another molecule to treat symptoms of dementia in Alzheimer’s patients.